Couldn't load pickup availability
Free delivery on orders above Rs 15,000 (otherwise Rs 450). 1–2 business days to major cities, 3–5 elsewhere.
We deliver across Pakistan, usually in 1–2 business days to major cities and 3–5 business days elsewhere. Delivery is free on orders above Rs 15,000; a flat Rs 450 applies to smaller orders. Cash on Delivery is available in Sindh; elsewhere, pay by bank transfer or card. Cold-chain medicines such as insulin are shipped in insulated packaging.
If an item arrives damaged, expired, defective, wrong or missing, tell us within 48 hours of delivery and send photos of the item and packaging. For your safety, opened medicines, dispensed prescription medicines and change-of-mind returns cannot be accepted. Approved refunds are processed within 7–10 business days, or as store credit for Cash on Delivery orders.
Arbi D combines Irbesartan 150mg and Hydrochlorothiazide 12.5mg, made by PharmEvo, Pakistan. It is a two-in-one tablet for high blood pressure. This medicine requires a prescription.
Irbesartan relaxes blood vessels by blocking angiotensin II receptors; hydrochlorothiazide is a diuretic that removes excess salt and water. Together they lower blood pressure more effectively.
Hypertension in adults not controlled on irbesartan (such as Arbi 150mg) or a diuretic alone.
One tablet once daily, preferably in the morning, with or without food, as directed by your doctor.
Dizziness, fatigue, increased urination, nausea, low potassium or sodium, and raised uric acid that may trigger gout.
Avoid in pregnancy, severe kidney or liver disease and sulfonamide allergy. Caution in diabetes, gout and lupus, and with lithium, NSAIDs or other diuretics. Blood tests for salts and kidney function may be needed. Store below 30°C.
What does the "D" mean? It indicates the added diuretic, hydrochlorothiazide.
Can I take it with food? Yes, food does not affect it.
Similar combination: Co-Aprovel 150/12.5. Browse more in our Blood Pressure Medicines collection.
See our full Shipping Policy and Refund Policy.
Thanks for subscribing!
This email has been registered!